7.91

3.30% -0.27

Pre-market: 6.70 -1.21 -15.30%

Neogenomics Inc (NEO)

Overview News Price History Option Chain Financials Why NEO Down? Discussions Forecast Stock Split

Neogenomics Inc stock is traded at $7.91, with a volume of 1.99M. It is down -3.30% in the last 24 hours and down -2.35% over the past month. NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Previous Close:

$8.18

Open:

$8.13

24h Volume:

1.99M

Relative Volume:

1.08

Market Cap:

$1.03B

Revenue:

$727.33M

Net Income/Loss:

$-108.03M

P/E Ratio:

-9.372

EPS:

-0.844

Net Cash Flow:

$-21.78M

1W Performance:

-3.06%

1M Performance:

-2.35%

6M Performance:

-24.31%

1Y Performance:

-20.18%

1-Day Range:

$7.69

$8.255

1-Week Range:

$7.69

$8.60

52-Week Range:

$4.72

$13.74

Neogenomics Inc Stock (NEO) Company Profile

Name

Neogenomics Inc

Sector

Healthcare (1111)

Industry

Diagnostics & Research (52)

Phone

(239) 768-0600

Address

9490 NEOGENOMICS WAY, FORT MYERS, FL

Employee

2,500

Twitter

@NeoGenomics

Next Earnings Date

2026-04-28

Latest SEC Filings

NEO's Discussions on Twitter

Compare NEO vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NEO Neogenomics Inc	7.91	1.04B	727.33M	-108.03M	-21.78M	-0.844
TMO Thermo Fisher Scientific Inc	466.70	194.94B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	178.57	137.69B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	560.93	45.19B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	114.42	34.50B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	311.20	32.91B	3.17B	642.63M	516.49M	10.77

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-30-25	Downgrade	BTIG Research	Buy → Neutral
Jul-29-25	Downgrade	William Blair	Outperform → Mkt Perform
May-15-25	Initiated	Guggenheim	Neutral
Apr-30-25	Downgrade	Leerink Partners	Outperform → Market Perform
Jan-13-25	Downgrade	The Benchmark Company	Buy → Hold
Dec-10-24	Initiated	Jefferies	Buy
May-01-24	Resumed	Craig Hallum	Buy
Dec-29-23	Reiterated	BTIG Research	Buy
Aug-21-23	Upgrade	Stephens	Equal-Weight → Overweight
May-16-23	Downgrade	Raymond James	Outperform → Mkt Perform
May-09-23	Upgrade	BTIG Research	Neutral → Buy
Feb-24-23	Upgrade	The Benchmark Company	Hold → Buy
Feb-01-23	Upgrade	Needham	Hold → Buy
Aug-26-22	Downgrade	The Benchmark Company	Buy → Hold
Aug-22-22	Downgrade	Needham	Buy → Hold
Jun-03-22	Initiated	Piper Sandler	Overweight
Mar-29-22	Downgrade	BofA Securities	Buy → Neutral
Mar-29-22	Downgrade	Stephens	Overweight → Equal-Weight
Jan-18-22	Resumed	Stephens	Overweight
Dec-16-21	Initiated	Cowen	Outperform
Nov-05-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-14-21	Upgrade	Raymond James	Mkt Perform → Outperform
Jun-03-21	Initiated	Goldman	Buy
Feb-25-21	Resumed	Needham	Buy
Feb-25-21	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-28-21	Initiated	Truist	Buy
Dec-11-20	Resumed	BTIG Research	Buy
Oct-28-20	Reiterated	Needham	Buy
Sep-09-20	Initiated	Morgan Stanley	Overweight
Aug-28-20	Initiated	Guggenheim	Buy
Jul-29-20	Reiterated	Needham	Buy
Jun-25-20	Initiated	BofA/Merrill	Buy
Apr-21-20	Resumed	Stephens	Overweight
Mar-02-20	Resumed	Craig Hallum	Buy
Feb-28-20	Upgrade	First Analysis Sec	Outperform → Strong Buy
Jan-23-20	Downgrade	First Analysis Sec	Strong Buy → Outperform
Oct-30-19	Reiterated	Needham	Buy
May-01-19	Reiterated	Needham	Buy
Mar-29-19	Reiterated	Needham	Buy
Jan-03-19	Initiated	Needham	Buy
Oct-24-18	Upgrade	First Analysis Sec	Outperform → Strong Buy
Aug-21-18	Initiated	Leerink Partners	Outperform
May-02-18	Downgrade	First Analysis Sec	Overweight → Equal-Weight
Sep-11-17	Downgrade	BTIG Research	Buy → Neutral
Aug-24-17	Initiated	Gabelli & Co	Buy
Dec-15-16	Initiated	Cantor Fitzgerald	Overweight

View All

Neogenomics Inc Stock (NEO) Latest News

Apr 23, 2026

NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration - PharmiWeb.com

Apr 23, 2026

NeoGenomics, Inc. Expands Oncology Testing Portfolio Access Through Epic Aura Integration - marketscreener.com

Apr 23, 2026

NeoGenomics integrates testing portfolio with Epic Aura EHR - Investing.com

Apr 23, 2026

NeoGenomics Expands Oncology Testing Access With Epic Aura EHR Integration - citybiz

Apr 23, 2026

Is NeoGenomics (NEO) stock showing signs of reversal | Q4 2025: EPS Exceeds ExpectationsWall Street Views - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026

NEO NeoGenomics posts 53.5 percent EPS beat in Q4 2025, yet shares drop 1.8 percent in today’s trading. - Cổng thông tin điện tử Tỉnh Sơn La

Apr 23, 2026

Earnings Preview: NeoGenomics to Report Financial Results Post-market on April 28 - Moomoo

Apr 23, 2026

Apr 21, 2026

NeoGenomics (NEO) Projected to Post Earnings on Tuesday - MarketBeat

Apr 21, 2026

NeoGenomics Inc stock (US64049M2098): Why does its oncology testing model matter more now? - AD HOC NEWS

Apr 21, 2026

Apr 20, 2026

NeoGenomics (NEO) Meets Q2 Earnings Estimates - MSN

Apr 20, 2026

Apr 18, 2026

NeoGenomics, Inc. Experiences Evaluation Revision Amidst Market Performance Challenges - Markets Mojo

Apr 18, 2026

Is NeoGenomics (NEO) stock forming lower lows (Bullish Momentum) 2026-04-18Low Risk Entry - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 18, 2026

Apr 16, 2026

NeoGenomics (NASDAQ:NEO) Stock Price Down 5.3%Here's What Happened - MarketBeat

Apr 16, 2026

Apr 15, 2026

NeoGenomics to Spotlight AI-Driven Genomic–Clinical Data Integration at AACR 2026 - Clinical Lab Products

Apr 15, 2026

Apr 14, 2026

NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Apr 14, 2026

Apr 13, 2026

Will NeoGenomics Inc outperform the market in YEAR2026 Earnings Impact & Community Shared Stock Ideas - baoquankhu1.vn

Apr 13, 2026

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack - Yahoo Finance

Apr 13, 2026

Guidance Update: Can NeoGenomics Inc deliver alpha2026 Chart Watch & Verified Momentum Stock Watchlist - baoquankhu1.vn

Apr 13, 2026

NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026 - National Today

Apr 13, 2026

Bearish Setup: Will NeoGenomics Inc stock hit new highs in YEAR2026 Historical Comparison & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Buybacks Report: Why is NeoGenomics Inc stock going up2026 Price Swings & Safe Swing Trade Setups - baoquankhu1.vn

Apr 13, 2026

Setup Watch: Can NeoGenomics Inc keep up with sector leaders2026 Levels & Daily Entry Point Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Tudor Investment Corp ET AL Trims NeoGenomics, Inc. $NEO Stake - National Today

Apr 11, 2026